J
Jimin Wu
Researcher at University of Texas MD Anderson Cancer Center
Publications - 86
Citations - 1657
Jimin Wu is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Palliative care & Cancer. The author has an hindex of 18, co-authored 81 publications receiving 1114 citations. Previous affiliations of Jimin Wu include University of Vermont & University of Texas Health Science Center at Houston.
Papers
More filters
Journal ArticleDOI
The frequency of missed delirium in patients referred to palliative care in a comprehensive cancer center
Maxine De La Cruz,Joanna Fan,Sriram Yennu,Kimberson Tanco,SeongHoon Shin,Jimin Wu,Diane Liu,Eduardo Bruera +7 more
TL;DR: Sixty-one percent of patients with a diagnosis of delirium by a palliative care specialist were missed by the primary referring team, and patients with MD were frequently referred for pain.
Journal ArticleDOI
Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients
Elizabeth Vera-Bolanos,Kenneth Aldape,Ying Yuan,Jimin Wu,Khalida Wani,Mary Jo T. Necesito-Reyes,Howard Colman,Girish Dhall,Frank S. Lieberman,Philippe Metellus,Tom Mikkelsen,Antonio Omuro,Sonia Partap,Michael D. Prados,H. Ian Robins,Riccardo Soffietti,Jing Wu,Mark R. Gilbert,Terri S. Armstrong +18 more
TL;DR: Findings from an ongoing, multicenter collaboration from a collection of clinically annotated adult ependymoma tumor samples demonstrating distinct predictors of progression-free survival are reported.
Journal ArticleDOI
Patterns of Storage, Use, and Disposal of Opioids Among Cancer Outpatients
Akhila Reddy,Maxine de la Cruz,Eden Mae Rodriguez,Jessica Thames,Jimin Wu,Gary B. Chisholm,Diane Liu,Susan Frisbee-Hume,Sriram Yennurajalingam,David Hui,Hilda Cantu,Alejandra Marin,Vicki Gayle,Nancy Shinn,Angela Xu,Janet L. Williams,Eduardo Bruera +16 more
TL;DR: A large proportion of cancer patients improperly and unsafely use, store, and dispose of opioids, highlighting the need for establishment of easily accessed patient education and drug take-back programs.
Journal ArticleDOI
The Impact of an Educational Program on Patient Practices for Safe Use, Storage, and Disposal of Opioids at a Comprehensive Cancer Center
Maxine de la Cruz,Akhila Reddy,Vishidha Reddy Balankari,Margeaux Chiou Epner,Susan Frisbee-Hume,Jimin Wu,Diane Liu,Sriram Yennuraialingam,Hilda Cantu,Janet L. Williams,Eduardo Bruera +10 more
TL;DR: It is demonstrated that the implementation of an opioid educational program and distribution of educational material on opioid safety brings about an improvement in opioid storage, use, and disposal practices in patients being prescribed opioids for cancer-related pain.
Journal ArticleDOI
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages.
John de Groot,Marta Penas-Prado,Kristin Alfaro-Munoz,Kathy Hunter,Be Lian Pei,Barbara O’Brien,Shiao Pei Weathers,Monica Loghin,Carlos Kamiya Matsouka,W. K. Alfred Yung,Jacob Mandel,Jimin Wu,Ying Yuan,Shouhao Zhou,Gregory N. Fuller,Jason T. Huse,Ganesh Rao,Jeffrey S. Weinberg,Sujit S. Prabhu,Ian E. McCutcheon,Frederick F. Lang,Sherise D. Ferguson,Raymond Sawaya,Rivka R. Colen,Shalini S. Yadav,Jorge Blando,Luis M Vence,James P. Allison,Padmanee Sharma,Amy B. Heimberger +29 more
TL;DR: Immune analyses indicated that pembrolizumab anti-programmed cell death 1 (PD-1) monotherapy alone can't induce effector immunologic response in most GBM patients, probably owing to a scarcity of T cells within the tumor microenvironment and a CD68+ macrophage preponderance.